Newswire (Published: Tuesday, January 10, 2017, Received: Saturday, January 7, 2017, 10:46:07 AM CST)

Word Count: 482

Findings on Prostate Cancer Detailed by Investigators at Duke University (Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions)

By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Prostate Cancer is the subject of a report. According to news reporting originating from Durham, North Carolina, by NewsRx correspondents, research stated, "To assess the influence of patient preferences and urologist recommendations in treatment decisions for clinically localized prostate cancer. We enrolled 257 men with clinically localized prostate cancer (prostate-specific antigen < 20; Gleason score 6 or 7) seen by urologists (primarily residents and fellows) in 4 Veterans Affairs medical centers."

Our news editors obtained a quote from the research from Duke University, "We measured patients' baseline preferences prior to their urology appointments, including initial treatment preference, cancer-related anxiety, and interest in sex. In longitudinal follow-up, we determined which treatment patients received. We used hierarchical logistic regression to determine the factors that predicted treatment received (active treatment v. active surveillance) and urologist recommendations. We also conducted a directed content analysis of recorded clinical encounters to determine if urologists discussed patients' interest in sex. Patients' initial treatment preferences did not predict receipt of active treatment versus surveillance, Delta chi(2) (4) = 3.67, P = 0.45. Instead, receipt of active treatment was predicted primarily by urologists' recommendations, Delta chi(2) (2) = 32.81, P< 0.001. Urologists' recommendations, in turn, were influenced heavily by medical factors (age and Gleason score) but were unrelated to patient preferences, Delta chi(2) (6) = 0, P = 1. Urologists rarely discussed patients' interest in sex (< 15% of appointments)."

According to the news editors, the research concluded: "Patients' treatment decisions were based largely on urologists' recommendations, which, in turn, were based on medical factors (age and Gleason score) and not on patients' personal views of the relative pros and cons of treatment alternatives."

For more information on this research see: Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions. Medical Decision Making, 2016;37(1):56-69. Medical Decision Making can be contacted at: Sage Publications Inc, 2455 Teller Rd, Thousand Oaks, CA 91320, USA. (Sage Publications -; Medical Decision Making -

The news editors report that additional information may be obtained by contacting P.A. Ubel, Duke University, Sanford Sch Public Policy, Durham, NC, United States. Additional authors for this research include A. Fagerlin, T. Hofer, L.D. Scherer, M. Holmes-Rovner, L.D. Williamson, V.C. Kahn, J.S. Montgomery, K.L. Greene, B.Q. Zhang and P.A. Ubel (see also Oncology - Prostate Cancer).

Keywords for this news article include: Durham, North Carolina, United States, North and Central America, Cancer, Epidemiology, Prostatic Neoplasms, Prostate Cancer, Oncology, Duke University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


Duke University
P-1 Enterprises Inc.
Sage Publications Inc.


Central America
North America
United States
North Carolina
Thousand Oaks


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Health Sciences
            Medical Research
      Medical Specialties and Practices